Latest Prenatal diagnosis Stories
When prenatal diagnosis detects the severe heart defect hypoplastic left heart syndrome (HLHS) in a fetus, a comprehensive prenatal evaluation is important to provide parents an accurate prognosis.
PHILADELPHIA, Oct. 26 /PRNewswire-USNewswire/ -- When prenatal diagnosis detects the severe heart defect hypoplastic left heart syndrome (HLHS) in a fetus, a comprehensive prenatal evaluation is important to provide parents an accurate prognosis.
Prenatal treatment of congenital toxoplasmosis with antibiotics might substantially reduce the proportion of infected fetuses that develop serious neurological sequelae (brain damage, epilepsy, deafness, blindness, or developmental problems) or die, and could be particularly effective in fetuses whose mothers acquired Toxoplasma gondii, the parasite that causes toxoplasmosis, during the first third of pregnancy.
Researchers say that a blood test during pregnancy could one day replace more invasive tests for Down's syndrome.
LONDON, June 30 /PRNewswire/ -- Frost & Sullivan is pleased to announce that it has awarded its prestigious 2010 Scandinavia New Product Innovation Award to FCMB ApS ("FCMB") for its breakthrough work in non-invasive prenatal testing.
BEIJING, April 29 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc.
New study in the American Journal of Obstetrics & Gynecology explores this controversy.
PARSIPPANY, N.J. and REDWOOD CITY, Calif., Feb. 25 /PRNewswire/ -- Ferring Pharmaceuticals and Gene Security Network (GSN) announced that they have signed an agreement to conduct a clinical trial of GSN's advanced preimplantation genetic diagnosis (PGD) technology, Parental Support(TM).
Repairing birth defects in the womb. Inserting a tiny laser into the mother's uterus to seal off an abnormal blood flow and save fetal twins. Advancing the science that may allow doctors to deliver cells or DNA to treat sickle cell anemia and other genetic diseases before birth.
SAN DIEGO, Feb. 16 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced the launch of the SensiGene(TM) Fetal(XY) (Fetal Sex Determination) test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM).
- Easily ashamed, having a strong sense of shame; modest; chaste.
- Of or pertaining to the external organs of generation.